Fundz

Acutis Biosciences Unveils State-of-the-Art Facility to Perform Integrated Biomarker and Data Analytics Services and Welcomes New Chief Commercial Officer for the Biopharma Market

PRIVATEJun 13, 2023

Position

Chief Commercial Officer

Company

Acutis Biosciences

Troy Tremaine
ttremaine@acutis.com
Monmouth JunctionBiotechnologyArtificial IntelligenceMachine Learning

Description

Acutis Biosciences is pleased to announce the opening of its state-of-the-art 60,000-square-foot facility in Monmouth Junction, New Jersey. Acutis Biosciences combines a multi-omics biomarker profiling approach with unparalleled data integration, thereby providing pharmaceutical and biotechnology companies with the tools needed to advance clinical discovery. This unique approach builds on the expertise gained through its standard-of-care business, Acutis Diagnostics, which has processed over three million patient samples over the past seven years with turnaround times that have been consistently at the top of the industry.","Furthermore, the company has named Troy Tremaine as its Chief Commercial Officer

Quick answer

Acutis Biosciences Unveils State-of-the-Art Facility to Perform Integrated Biomarker and Data Analytics Services and Welcomes New Chief Commercial Officer for the Biopharma Market (June 13, 2023). Acutis Biosciences is based in Monmouth Junction, New Jersey, United States.

What did Acutis Biosciences announce on June 13, 2023?
Acutis Biosciences is pleased to announce the opening of its state-of-the-art 60,000-square-foot facility in Monmouth Junction, New Jersey. Acutis Biosciences combines a multi-omics biomarker profiling approach with unparalleled data integration, thereby providing pharmaceutical and biotechnology companies with the tools needed to advance clinical discovery.
What does Acutis Biosciences do?
Acutis Biosciences is a biomarker discovery provider to biopharmaceutical companies with next-generation multi-omics biomarker analysis solutions powered by machine learning (ML) and AI.
Where is Acutis Biosciences based?
Acutis Biosciences is based in Monmouth Junction, New Jersey, United States.
Which similar companies made leadership changes around the same time?
STELLA™ Automotive AI (June 13, 2023), KNOWN (June 12, 2023), Elliptic Labs (June 20, 2023) and PixCell Medical (June 20, 2023) also announced leadership changes within 45 days of Acutis Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Artificial Intelligence

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Acutis Biosciences, and when

A new leader at Acutis Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Acutis Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Acutis Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Acutis Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Acutis Biosciences

Location

Monmouth Junction, New Jersey, United States

About

Acutis Biosciences is a biomarker discovery provider to biopharmaceutical companies with next-generation multi-omics biomarker analysis solutions powered by machine learning (ML) and AI. With technology platforms in genomics and histopathology for development and validation of state-of-the-art cancer molecular diagnostic assays, in oncology, immuno-oncology and infectious diseases, Acutis redefines conventions with a unique customer engagement model coupled to extraordinary science.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Acutis Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Troy
Likely contact at this company
••••••••@••••••••

See Troy's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Acutis Biosciences's next move

Learn about Strategic plan

Acutis Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.